 I. To determine the objective clinical response rate of AEB071 sotrastaurin acetate treatment in patients with relapsed or refractory chronic lymphocytic leukemia CLLsmall lymphocytic leukemia SLLprolymphocytic leukemia PLLRichters transformation RT. 